Company / Depreciation & Amortization
NextCure, Inc. Depreciation & Amortization History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.4M
FY2021
5-year range
$1.7M / $3.4M
FY2019-FY2021
Trend
+26.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2021.
Increased from $2M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, depreciation & amortization increased 26.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $3.4M | +26.5% |
| FY2020 | $2.7M | +60.3% |
| FY2019 | $1.7M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026